Johnl Perez News Today

AstraZeneca Vietnam has received the British Chamber of Commerces first-ever 50th Anniversary Recognition award.

Sylvia Varela, Asia Area vice president at AstraZeneca, spoke to VIR’s Bich Thuy about how AstraZeneca is pushing for gender equality in Vietnam.

AstraZeneca Vietnam and Cho Ray Hospital have signed an MoU to continue their commitment to improving healthcare.

AstraZeneca Vietnam has received a certificate of merit from Prime Minister Pham Minh Chinh for the company’s exceptional contributions to Vietnam’s vaccine diplomacy efforts.

AstraZeneca Vietnam has been recognised as one of Vietnam’s top 100 best places to work in 2022 for the fourth consecutive year.

Last week marked an important step in AstraZeneca’s journey in Vietnam. On his visit to Hanoi, Dr. John L. Perez, senior vice president of the Vaccines and Immune Therapies Unit at AstraZeneca, talked to VIR’s Bich Thuy about the company’s future ambition and ongoing efforts to increase Vietnamese patients’ early access to new medicines.

AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442) retains neutralisation activity against the emerging Omicron BA.4 and BA.5 (BA.4/5) variants, says preclinical pseudovirus assay data from the University of Oxford.